For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Scope of the Report:
This report focuses on the Pimozide in United States market, to split the market based on manufacturers, states, type and application.
Market Segment by Manufacturers, this report covers"
- Par Pharmaceutical
- Johnson & Johnson
- Domina Pharmaceuticals
- Aa Pharma
Market Segment by States, covering
- New York
Market Segment by Type, covers
Market Segment by Applications, can be divided into
There are 17 Chapters to deeply display the United States Pimozide market.
Chapter 1, to describe Pimozide Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Pimozide, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Pimozide, for each state, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;
Chapter 12, Pimozide market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 15, to describe sales channel, distributors, traders, dealers, etc.
Chapter 16 and 17, to describe Pimozide Research Findings and Conclusion, Appendix, methodology and data source.